Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 9/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | PDE4A | P27815 | 16/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 16/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 16/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 16/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5776844 | 0.94 | CYP2C9 (0.52) | CYP2C9PTGS2PTGS1PDE4APDE4B | |
| SCHEMBL5776143 | 0.90 | CYP2C9 (0.50) | CYP2C9PTGS2PTGS1PDE4APDE4B | |
| SCHEMBL5780645 | 0.89 | CYP2C9 (0.47) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5776372 | 0.89 | PDE4A (0.49) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5779217 | 0.88 | CYP2C9 (0.48) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5776676 | 0.86 | CYP2C9 (0.50) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5780341 | 0.85 | PDE4A (0.51) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5775048 | 0.85 | CYP2C9 (0.44) | CYP2C9PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL5775713 | 0.85 | PTGS1 (0.56) | CYP2C9PTGS2PTGS1PDE4APDE4B | |
| SCHEMBL5778770 | 0.85 | CYP2C9 (0.51) | CYP2C9PDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1635829-A1 | 8-(3-BIARYL)PHENYLQUINOLINE PHOSPHODIESTERASE-4-INHIBITORS | Merck Frosst Canada Ltd. (CA) | 2006-03-22 | — | — | EP | claimed |
| WO-2004096220-A1 | 8-(3-BIARYL)PHENYLQUINOLINE PHOSPHODIESTERASE-4-INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2004-11-11 | — | — | WO | claimed |
| EP-1635829-A1 | 8-(3-BIARYL)PHENYLQUINOLINE PHOSPHODIESTERASE-4-INHIBITORS | Merck Frosst Canada Ltd. (CA) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004096220-A1 | 8-(3-BIARYL)PHENYLQUINOLINE PHOSPHODIESTERASE-4-INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2004-11-11 | — | — | WO | disclosed |